Trending...
- Making Time for Mythic Adventure - 201
- California: Governor Newsom signs new law to protect workers, require disclosures on AI-generated advertising - 132
- California: Governor Newsom signs legislation 9.14.2026 - 120
LOS ANGELES--(BUSINESS WIRE)--Respira Technologies, Inc.—a clinical-stage company developing inhaled therapeutics for smoking cessation and drug delivery technologies to treat cardiopulmonary diseases—has appointed former Altria Group executive and current Respira COO Brian Quigley as its new Chief Executive Officer. Respira's founder, Mario Danek, will transition to the role of Chief Technology Officer.
Quigley spent 16 years at Altria Group, with seven years as President & CEO at Altria's Smokeless and Innovative Products/Vapor Businesses. Quigley has been an active investor in both the cannabis and alcohol spaces and sits on the boards of Mustgrow Biologics and Belle Isle Craft Spirits.
With Respira in the midst of securing financing for clinical trials, Danek made a significant change to the structure of the company's leadership team. Quigley's background as a successful business leader and Fortune 150 CEO in the space will help drive Respira to its next phase as it advances to an IND submission to begin human clinical trials. This transition will enable Danek to focus on the technology behind Respira, concentrating on inventing and refining its innovative inhalation device across multiple potential indication areas and target markets.
More on The Californer
Respira, where Quigley spent the past two years as COO, is a California venture-backed health tech company focused on commercializing proprietary inhalation device technologies to improve patient outcomes. The company is currently engaged with FDA CEDR to pursue a combination product authorization as the first inhalable prescription smoking cessation therapy.
About Respira Technologies, Inc.
Respira, based in Los Angeles, was founded by Mario Danek in 2018 to build cutting-edge drug delivery platforms that improve patient outcomes through superior device technologies.
The company's key product, the RespiRx™, is the first orientation-agnostic, portable VMN device that effectively operates in any position held by the patient. Respira sees significant opportunity to utilize its drug delivery technologies to improve the treatment of Asthma, COPD, Vaccine Delivery, Pain Management, and several generic as well as select investigational new drugs with safe and effective inhalable drug delivery mechanisms that only the RespiRx™ can deliver.
Respira is backed by venture firms Blue Ledge Capital, DG Ventures, Evolution VC Partners, and Poseidon Asset Management.
Contacts
Investor Relations:
Respira Technologies, Inc.
IR@Respiratechnologies.com
Media Relations:
Richard Laermer
RLM PR
212-741-5106 X 216
Respira@RLMpr.com
Quigley spent 16 years at Altria Group, with seven years as President & CEO at Altria's Smokeless and Innovative Products/Vapor Businesses. Quigley has been an active investor in both the cannabis and alcohol spaces and sits on the boards of Mustgrow Biologics and Belle Isle Craft Spirits.
With Respira in the midst of securing financing for clinical trials, Danek made a significant change to the structure of the company's leadership team. Quigley's background as a successful business leader and Fortune 150 CEO in the space will help drive Respira to its next phase as it advances to an IND submission to begin human clinical trials. This transition will enable Danek to focus on the technology behind Respira, concentrating on inventing and refining its innovative inhalation device across multiple potential indication areas and target markets.
More on The Californer
- A3 Analytics Names Greg Snyder as Co-Founder and Chief Operating Officer
- California: Governor Newsom expands film and TV tax credits with new legislation, creates tax credit to support post-production jobs
- KayeDinero Writes Python. Does That Make Her an AI Artist? "C'mon Nah."
- Governor Newsom signs new laws to protect California elections from Trump interference
- Governor Newsom signs bill to protect California's sovereignty and guard against unauthorized military deployments
Respira, where Quigley spent the past two years as COO, is a California venture-backed health tech company focused on commercializing proprietary inhalation device technologies to improve patient outcomes. The company is currently engaged with FDA CEDR to pursue a combination product authorization as the first inhalable prescription smoking cessation therapy.
About Respira Technologies, Inc.
Respira, based in Los Angeles, was founded by Mario Danek in 2018 to build cutting-edge drug delivery platforms that improve patient outcomes through superior device technologies.
The company's key product, the RespiRx™, is the first orientation-agnostic, portable VMN device that effectively operates in any position held by the patient. Respira sees significant opportunity to utilize its drug delivery technologies to improve the treatment of Asthma, COPD, Vaccine Delivery, Pain Management, and several generic as well as select investigational new drugs with safe and effective inhalable drug delivery mechanisms that only the RespiRx™ can deliver.
Respira is backed by venture firms Blue Ledge Capital, DG Ventures, Evolution VC Partners, and Poseidon Asset Management.
Contacts
Investor Relations:
Respira Technologies, Inc.
IR@Respiratechnologies.com
Media Relations:
Richard Laermer
RLM PR
212-741-5106 X 216
Respira@RLMpr.com
Filed Under: Business
0 Comments
Latest on The Californer
- Treo expands global distribution across 17+ streaming FAST and connected TV platforms
- California: Governor Newsom announces Judicial Appointments 9.18.2026
- Mystery Enterprises Receives Federal Trademark Registration for Automated Murder Mystery Game Format
- Matt Zavala of Zavala Law, PC Selected to the 2027 Super Lawyers List
- Sawgrass Ford President Attributes Dealerships Success to Long-Term Employees
- Attn: Art Editors and Art Critics: At a Multimillion dollar Art Auction, does the Second-place Bidder breathe a Sigh of Relief or a Sigh of Regret?
- Governor Newsom proclaims California POW/MIA Recognition Day
- Cal State LA Professor Stephen Rothman's 'Effortless Perfection' earns festival recognition
- Nationwide Boiler Appoints John McDonough As Chief Operating Officer
- Senior Travel Deal Of The Week: 16-Day Morocco Adventure Drops From $4,295 To $995
- Ragin' Cajun Announces New Cheeseburger Seasoning on National Cheeseburger Day
- Warrant Activity, AVERSA™ Progress and a Potentially Transformative Fall Take Center Stage: Nutriband Inc. (N A S D A Q: NTRB)
- California: Governor Newsom issues executive order to accelerate independent oversight and advance the creation of an AI kill switch
- Manuel Jesse Lopez Expands Amazon Influencer Storefront To Global Audience
- xBxBio Opens EU, Asia and Latin America Regulatory Leadership Searches
- TitleChain Foundation Opens Public Commons Reference Project for Real-World Asset Transfer
- Put Your Herd on Your Phone: Kiko Nation Makes Livestock Management Simple
- Chapter Enterprise and NuGuard AI Announce Strategic Partnership to Make Enterprise Agentic AI Both Role-Intelligent and Audit-Ready
- iSmile Orthodontics - San Ramon Trains Its Whole Team on AI, Invites Other Practices to Join
- Future Intelligence Think Tank Surpasses 1,000 Members Exploring Human and Artificial Intelligence